4.7 Letter

Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs

Journal

CELL DISCOVERY
Volume 8, Issue 1, Pages -

Publisher

SPRINGERNATURE
DOI: 10.1038/s41421-022-00454-7

Keywords

-

Categories

Funding

  1. National Natural Science Foundation of China [81788101]
  2. Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences [2021-I2M-1-022, 2021-I2M-1-062]
  3. CAMS Endowment Fund [2021-CAMS-JZ001]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available